Recalls / Generics / Empagliflozin And Linagliptin
Empagliflozin And Linagliptin
1 FDA drug recall involving generic “Empagliflozin And Linagliptin”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boeh | Cardinal Health Inc. |